Pen Needles Market Size, Share, Future Analysis, 2026-2034

Market Overview

According to fortune business insights, the global pen needles market size was valued at USD 2.41 billion in 2025. The market is projected to grow from USD 2.56 billion in 2026 to USD 4.58 billion by 2034, exhibiting a CAGR of 7.50% during the forecast period. North America dominated the pen needles market with a market share of 39.60% in 2025.

The analysis shows that the increasing prevalence of diseases such as diabetes, osteoporosis, and growth hormone deficiency, coupled with the increased usage of injection pens for drug delivery, is driving market growth. For instance, Ypsomed reported in November 2023 that sales of its UnoPen and YpsoPen injections exceeded 100 million and 10 million units, respectively, indicating strong demand.

Major Players Profiled in the Market Report:

• Novo Nordisk A/S (Denmark)

• Embecta Corp. (U.S.)

• B. Braun SE (Germany)

• Owen Mumford (U.K.)

• BD (U.S.)

• Cardinal Health (U.S.)

• SOL-Millennium (U.S.)

• Terumo Corporation (Japan)

• MTD Medical Technology and Devices S.p.A. (Italy)

• UltiMed, Inc. (U.S.)

• Allison Medical, Inc. (U.S.)

Segments

Increasing Prevalence of Diseases to Fuel Demand for Standard Pen NeedlesBy product type, the market is segmented into standard pen needles and safety pen needles. The standard pen needles segment is projected to hold the largest market share (67.97% in 2026) due to the high prevalence of diseases like diabetes and less awareness regarding needlestick injuries.

Growing Demand for Insulin Pens to Drive Insulin Segment GrowthBased on drug type, the market is divided into insulin, GLP-1, growth hormone, and others. The insulin segment is expected to dominate, accounting for a 75.39% market share in 2026, driven by strong demand for insulin in diabetes management.

Rising Diabetes Cases to Propel Diabetes SegmentBy disease indication, the market is categorized into diabetes, obesity, hormone deficiency, and others. The diabetes segment is projected to lead with an 83.59% market share in 2026, fueled by the rising prevalence of the disease and new product launches.

Safety and Efficacy to Drive 4 mm Needle Segment ExpansionBased on needle size, the market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, and 12 mm. The 4 mm needle segment is projected to dominate with a 49.61% share in 2026, as it lowers the risk of intramuscular injection.

High Patient Preference for At-Home Convenience to Boost Retail Pharmacy SegmentBy distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment holds the largest market share due to patient preference for easy, at-home drug delivery. The online pharmacy segment is expected to be the fastest-growing.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

For detailed market insights: https://www.fortunebusinessinsights.com/pen-needles-market-110437

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• A list of major industry players and their profiles.

• Key strategies adopted by market players, such as partnerships, mergers, and acquisitions.

• The latest industry developments, including new solution launches.

Drivers & Restraints

Increasing Demand for Effective Treatment to Propel Market GrowthThe growing burden of chronic diseases such as diabetes, osteoporosis, and growth hormone deficiency is fueling the demand for effective drug delivery devices like pen injections, thereby driving the pen needles market. For example, in 2021, 10.5% of the global adult population had diabetes, a figure expected to grow by 46% by 2045.

However, risk factors associated with needle use, such as injection-site reactions (allergy, lipoatrophy) and the risk of transmitting infections, may hamper market growth. The availability of alternate treatments like oral medicines also poses a challenge.

Regional Insights

Strong Presence of Key Players Propels Market Growth in North AmericaNorth America holds the dominant market share, valued at USD 0.96 billion in 2025. The region's growth is attributed to the strong presence of key players and high disease prevalence. The U.S. market is projected to reach USD 0.96 billion in 2026.

Asia Pacific is one of the fastest-growing regions, with a market value of USD 0.48 billion in 2025. Growth is driven by the increasing focus of pharmaceutical companies on launching injection pens in the region.

Europe held a market value of USD 0.65 billion in 2025, driven by a high burden of diabetes and a preference for self-administration of insulin.

Pen Needles Market Trends

Market players are focusing on enhancing their product offerings and expanding accessibility to meet the rising demand for advanced drug delivery devices. This includes new product launches, strategic acquisitions, and making products available over-the-counter (OTC). For example, in April 2024, MTD Medical Technology and Devices S.p.A. made its Droplet Micron portfolio available as OTC products in the U.S.

Competitive Landscape

Focus on New Product Launches and Strategic Partnerships to Enhance GrowthThe market features prominent players like Novo Nordisk A/S, Terumo Corporation, and MTD Medical Technology and Devices S.p.A. These companies are accelerating growth through strategies such as new product launches, acquisitions, and partnerships to expand their product portfolios and global reach.

Key Industry Developments

• April 2024: MTD Medical Technology and Devices S.p.A. expanded the indication of its pen needles to include GLP-1 and other therapies.

• March 2024: Owen Mumford partnered with Duopharma Biotech Berhad to distribute its diabetes and eye care products in Malaysia and Brunei.

• June 2023: Novo Nordisk A/S entered negotiations to acquire BIO JAG to enhance its drug-delivery device portfolio.

• May 2022: F. Hoffmann-La Roche Ltd launched Accu-Fine pen needles in India.

What Everyone Should Know About Japan’s Market Pen Needles Market Insights